Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1995 Dec;48(6):M326–M332. doi: 10.1136/mp.48.6.m326

Induction of intercellular adhesion molecule 1 and class II histocompatibility antigens in colorectal tumour cells expressing activated ras oncogene

V Stoneman 1, A Morris 1
PMCID: PMC408000  PMID: 16696033

Abstract

Aims—To determine whether there is a correlation between activation of the ras oncogene and the induction of MHC class II antigens and intercellular adhesion molecule 1 (ICAM-1) by interferon-γ (IFN-γ).

Methods—Expression of class II antigens, ICAM-1 and intracellular ras oncoprotein (p21) in established colorectal cell lines and short term cultures of primary colorectal tumour cells was determined by flow cytometry and mutation in the ras gene by sequencing of amplified segments of the gene.

Results—The cell lines showed a variation in their modulation of MHC class II antigens and ICAM-1, ranging from no induction to a 98-fold increase in class II antigen expression in the HT29 cell line. Previous work indicated that most tumours could not be induced to express class II antigens. Four of the five least inducible lines either contained mutant ras or highly expressed the oncoprotein. The four highly inducible cell lines all contained non-mutant ras. Of the 21 tumours studied in primary culture, 10 were inducible, one of which contained mutant ras. Of the remaining non-inducible tumours, four were mutant.

Conclusions—Correlations between ras activation and failure to respond to IFN-γ could not be shown to be significant. Therefore, ras activation, and concomitant subversion of intracellular signalling pathways, is probably not the major determinant in failure to activate class II antigens and ICAM-1.

Keywords: Histocompatibility antigens

Keywords: intercellular adhesion molecule 1

Keywords: ras

Full text

PDF
M326

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen C. B., Ladefoged S. D., Larsen S. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. APMIS. 1994 Jan;102(1):23–37. [PubMed] [Google Scholar]
  2. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
  3. Bateman W. J., Fiera R., Matthews N., Morris A. G. Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras. J Exp Med. 1991 Jan 1;173(1):193–196. doi: 10.1084/jem.173.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benveniste E. N., Vidovic M., Panek R. B., Norris J. G., Reddy A. T., Benos D. J. Interferon-gamma-induced astrocyte class II major histocompatibility complex gene expression is associated with both protein kinase C activation and Na+ entry. J Biol Chem. 1991 Sep 25;266(27):18119–18126. [PubMed] [Google Scholar]
  5. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  6. Brunner C. A., Gokel J. M., Riethmüller, Johnson J. P. Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognois. Eur J Cancer. 1991;27(4):411–416. doi: 10.1016/0277-5379(91)90374-m. [DOI] [PubMed] [Google Scholar]
  7. Darnell J. E., Jr, Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994 Jun 3;264(5164):1415–1421. doi: 10.1126/science.8197455. [DOI] [PubMed] [Google Scholar]
  8. Esteban F., Ruiz-Cabello F., Concha A., Pérez-Ayala M., Sánchez-Rozas J. A., Garrido F. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis. 1990 Jul-Aug;8(4):319–328. doi: 10.1007/BF01810678. [DOI] [PubMed] [Google Scholar]
  9. Fan X. D., Goldberg M., Bloom B. R. Interferon-gamma-induced transcriptional activation is mediated by protein kinase C. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5122–5125. doi: 10.1073/pnas.85.14.5122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Finkelstein S. D., Sayegh R., Christensen S., Swalsky P. A. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 1993 Jun 15;71(12):3827–3838. doi: 10.1002/1097-0142(19930615)71:12<3827::aid-cncr2820711207>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  11. Friedman D. J., Ricciardi R. P. Adenovirus type 12 E1A gene represses accumulation of MHC class I mRNAs at the level of transcription. Virology. 1988 Jul;165(1):303–305. doi: 10.1016/0042-6822(88)90689-7. [DOI] [PubMed] [Google Scholar]
  12. Fu X. Y., Zhang J. J. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell. 1993 Sep 24;74(6):1135–1145. doi: 10.1016/0092-8674(93)90734-8. [DOI] [PubMed] [Google Scholar]
  13. Hilton D. A., West K. P. An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma. Cancer. 1990 Sep 15;66(6):1154–1157. doi: 10.1002/1097-0142(19900915)66:6<1154::aid-cncr2820660613>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  14. Hume C. R., Accolla R. S., Lee J. S. Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8603–8607. doi: 10.1073/pnas.84.23.8603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Liu M. K., Brownsey R. W., Reiner N. E. Gamma interferon induces rapid and coordinate activation of mitogen-activated protein kinase (extracellular signal-regulated kinase) and calcium-independent protein kinase C in human monocytes. Infect Immun. 1994 Jul;62(7):2722–2731. doi: 10.1128/iai.62.7.2722-2731.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lu Y., Ussery G. D., Muncaster M. M., Gallie B. L., Blanck G. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogene. 1994 Apr;9(4):1015–1019. [PubMed] [Google Scholar]
  17. Marquardt B., Frith D., Stabel S. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene. 1994 Nov;9(11):3213–3218. [PubMed] [Google Scholar]
  18. McCormick F. Activators and effectors of ras p21 proteins. Curr Opin Genet Dev. 1994 Feb;4(1):71–76. doi: 10.1016/0959-437x(94)90093-0. [DOI] [PubMed] [Google Scholar]
  19. McDonald G. B., Jewell D. P. Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon. J Clin Pathol. 1987 Mar;40(3):312–317. doi: 10.1136/jcp.40.3.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Morris A. G., Ward G. A., Bateman W. J. Interaction of v-Ki-ras oncogene and interferon-gamma in the control of histocompatibility antigen expression in mouse fibroblasts. Cell Immunol. 1989 May;120(2):470–476. doi: 10.1016/0008-8749(89)90214-1. [DOI] [PubMed] [Google Scholar]
  21. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992 Oct 23;258(5082):607–614. doi: 10.1126/science.1411571. [DOI] [PubMed] [Google Scholar]
  22. Ostrand-Rosenberg S., Thakur A., Clements V. Rejection of mouse sarcoma cells after transfection of MHC class II genes. J Immunol. 1990 May 15;144(10):4068–4071. [PubMed] [Google Scholar]
  23. Ruff-Jamison S., Chen K., Cohen S. Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science. 1993 Sep 24;261(5129):1733–1736. doi: 10.1126/science.8378774. [DOI] [PubMed] [Google Scholar]
  24. Sadowski H. B., Shuai K., Darnell J. E., Jr, Gilman M. Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science. 1993 Sep 24;261(5129):1739–1744. doi: 10.1126/science.8397445. [DOI] [PubMed] [Google Scholar]
  25. Schrier P. I., Peltenburg L. T. Relationship between myc oncogene activation and MHC class I expression. Adv Cancer Res. 1993;60:181–246. doi: 10.1016/s0065-230x(08)60826-x. [DOI] [PubMed] [Google Scholar]
  26. Seeburg P. H., Colby W. W., Capon D. J., Goeddel D. V., Levinson A. D. Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature. 1984 Nov 1;312(5989):71–75. doi: 10.1038/312071a0. [DOI] [PubMed] [Google Scholar]
  27. Shuai K., Ziemiecki A., Wilks A. F., Harpur A. G., Sadowski H. B., Gilman M. Z., Darnell J. E. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature. 1993 Dec 9;366(6455):580–583. doi: 10.1038/366580a0. [DOI] [PubMed] [Google Scholar]
  28. Todd I., Hammond L. J., James R. F., Feldmann M., Bottazzo G. F. Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells. Immunology. 1990 Jan;69(1):91–96. [PMC free article] [PubMed] [Google Scholar]
  29. Tsomides T. J., Eisen H. N. T-cell antigens in cancer. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3487–3489. doi: 10.1073/pnas.91.9.3487. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES